Skip to content

Quality of life in head and neck cancer follow-up clinics

Quality of life driven consultations in head and neck cancer follow-up: a mixed methods feasibility study in nurse and doctor led clinics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12861667
Enrollment
44
Registered
2010-09-02
Start date
2010-07-09
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer Cancer Head and neck cancer

Interventions

The intervention involves the use of a validated quality of life questionnaire - the FACT HN - on a tablet touch screen computer in both nurse-led and doctor-led clinics. The impact of the questionnai

Sponsors

University Hospitals Coventry and Warwickshire NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with early or advanced oral/oropharyngeal and laryngeal cancer who have completed curative treatment 1 - 12 months previously 2. Attend head and neck follow-up clinic 3. Male and female patients age 18 years or over 4. The ability to communicate in and read English 5. The ability to give informed consent

Exclusion criteria

Exclusion criteria: 1. Patients undergoing treatment for palliation 2. Patients with cancers that are not laryngeal or oral/oropharyngeal

Design outcomes

Primary

MeasureTime frame
Percentage of patients showing improvement in the Consultation and Relational Skills Questionnaire (CARE), measured at baseline consultation and intervention consultation

Secondary

MeasureTime frame
1. Patient Enablement Instrument (PEI), measured at baseline consultation and intervention consultation 2. Perceived Involvement in Care Scale (PICS) for patients, measured at baseline consultation and intervention consultation 3. European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30), measured at 4 - 6 weeks following the intervention 4. European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Specific Questionnaire (EORTC QLQ-HN35), measured at 4 - 6 weeks following the intervention

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026